Antonie van Leeuwenhoek

, Volume 52, Issue 3, pp 219–220 | Cite as

Group A meningococcal polysaccharide vaccine

What was learned from its use in Finland in 1973–1975 (A review)
  • P. H. Mäkelä


Polysaccharide Polysaccharide Vaccine Meningococcal Polysaccharide Meningococcal Polysaccharide Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. KäyhtyH., KarankoV., PeltolaH., SarnaS. & MäkeläP. H. (1980) Serum antibodies to capsular polysaccharide vaccine of group ANeisseria meningtidis followed for three years in infants and children. J. Infect. Dis. 142: 861–868Google Scholar
  2. KäyhtyH., JousimiesH., PeltolaH. & MäkeläP. H. (1981) Antibody response to capsular polysaccharides of groups A and CNeisseria meningitidis andHaemophilus influenzae type b during bacteremic disease. J. Infect. Dis. 143: 32–41Google Scholar
  3. KuronenT., PeltolaH., NorsT., HaqueN. & MäkeläP. H. (1977) Adverse reactions and endotoxin content of polysaccharide vaccines. Develop. biol. Standard 34: 117–125Google Scholar
  4. Mäkelä, P. H., Käyhty, H., Weckström, P., Sivonen, A. & Renkonen, O.-V. (1975). Effect of group A meningococcal vaccine in army recruits in Finland. Lancet ii: 883–886Google Scholar
  5. PeltolaH., MäkeläP. H., KäyhtyH., JousimiesH., HervaE., HällströmK., SivonenA., RenkonenO.-V., PettayO., KarankoV., AhvonenP. & SarnaS. (1977) Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N. Engl. J. Med. 297: 686–691Google Scholar

Copyright information

© Martinus Nijhoff Publishers 1986

Authors and Affiliations

  • P. H. Mäkelä
    • 1
  1. 1.National Public Health InstituteHelsinkiFinland

Personalised recommendations